Article Text
Commentary
General medicine
Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear
Statistics from Altmetric.com
Footnotes
Contributors HAS wrote the manuscript and was solely responsible for concept and design, critical revision of the intellectual content and final approval.
Competing interests HAS: consultancy (Agios), outside of the topic of the submitted work.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.